Abstract
The recurrence and survival rates in patients with curable gastric cancer remain suboptimal. Debate on the optimal extent of lymphadenectomy for the surgical treatment of these patients is, therefore, still ongoing. A randomized, controlled trial by Sasako et al. has examined whether addition of para-aortic nodal dissection to D2 lymphadenectomy improves survival in patients with gastric cancer. The study included 523 patients who were randomly assigned either D2 lymphadenectomy or D2 lymphadenectomy and para-aortic nodal dissection. The results from this trial, whose primary end point was overall survival, demonstrated no additional benefit of lymphadenectomy beyond D2 resection. Management strategies should focus on optimal lymphadenectomy in high-volume hospitals, with evaluation of chemotherapy and radiotherapy, to achieve low surgery-related morbidity and mortality, optimal locoregional control and improved survival rates for patients with curable gastric cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hartgrink HH et al. (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22: 2069–2077
Cuschieri A et al. (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79: 1522–1530
Wu CW et al. (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7: 309–315
Sasako M et al. (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359: 453–462
Hundahl SA et al. (2007) Improved regional control and survival with “low Maruyama Index” surgery in gastric cancer: autopsy findings from the Dutch D1-D2 Trial. Gastric Cancer 10: 84–86
MacDonald JS et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725–730
Bilimoria KY et al. (2008) Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol 26: 4626–4633
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Songun, I., van de Velde, C. How does extended lymphadenectomy influence practical care for patients with gastric cancer?. Nat Rev Clin Oncol 6, 66–67 (2009). https://doi.org/10.1038/ncponc1300
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc1300